Jack S. Bodner

Partner

jbodner@cov.com
Download V-card

Covington & Burling LLP
The New York Times Building
620 Eighth Avenue
New York, NY 10018-1405
Tel: 212.841.1079
Mobile: 917.837.6708
Fax: 646.441.9079


 

Practices

Industries

Education

  • New York University School of Law, J.D.
    • Order of the Coif
  • New York University, B.A.
    • magna cum laude
    • Phi Beta Kappa

Bar Admissions

  • New York


Jack S. Bodner is a partner in the firm’s Mergers and Acquisitions and Corporate Governance groups.  He has extensive experience in advising acquirors, targets, investors, boards of directors, special committees and investment banks in domestic and cross-border negotiated and unsolicited mergers and acquisitions transactions.

Mr. Bodner’s practice also includes counseling clients on a variety of corporate and governance related matters, including compliance and disclosure issues, board and committee charters and policies, shareholder rights plans and proxy contests, and other defense and takeover measures.

Representative Matters

  • King Pharmaceuticals in its $3.6 billion merger with Pfizer.
  • Financial Federal Corporation in its $738 million sale to People’s United Financial, Inc.
  • OptiSolar Inc. in connection with the $400 million sale of its project development business to First Solar, Inc.
  • Financial Advisor to IMS Health Incorporated in its $5.2 billion going private transaction.
  • Mainfreight Limited in its acquisition of AMEX-listed Target Logistics, Inc.
  • Financial advisor to the Affiliated Transaction Committee of Coca-Cola Enterprises on the sale of its North American bottling operations to The Coca-Cola Company and its acquisition of Coca-Cola’s Norway and Sweden bottling businesses in a transaction valued at approximately $13 billion.
  • Financial advisor to Chrysler LLC in connection with its restructuring and sale to a consortium controlled by Fiat.
  • Financial advisor to Applera Corporation in connection with the $6.7 billion sale of Applera’s Applied Biosystems Group to Invitrogen Corp.
  • Lottomatica S.p.A. in connection with Lottomatica’s $4.8 billion acquisition of GTECH Holdings Corporation.
  • Financial advisor to Cougar Biotechnology, Inc. in its $970 million sale to Johnson & Johnson.
  • Financial advisor to Getinge AB in connection with its $865 million acquisition of Datascope Corp.
  • Financial advisor to Celgene Corporation in its $2.9 billion acquisition of Pharmion Corporation.

Honors and Rankings

  • Legal 500 US, Mergers, Acquisitions & Buyouts - M&A: Large Deals (2012-2013)
  • New York Super Lawyers (2011)

Publications and Speeches

Print PDF Word Version Print this page